Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.8100 (-1.64%) ($7.8100 - $7.8100) on Tue. Feb. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.36% (three month average) | RSI | 71 | Latest Price | $7.8100(-1.64%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 3.3% a day on average for past five trading days. | Weekly Trend | CAPR advances 9.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) VCIT(78%) JNK(67%) SPY(65%) EMHY(64%) IVE(59%) | Factors Impacting CAPR price | CAPR will decline at least -3.68% in a week (0% probabilities). VXX(-28%) UUP(-26%) USO(-7%) TBT(-24%) PEJ(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -3.68% (StdDev 7.36%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.21(8.32%) | 10 Day Moving Average | $6.8(14.85%) | 20 Day Moving Average | $6.18(26.38%) | To recent high | -1.6% | To recent low | 48.8% | Market Cap | $154m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |